[go: up one dir, main page]

ATE207351T1 - Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden - Google Patents

Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden

Info

Publication number
ATE207351T1
ATE207351T1 AT94919708T AT94919708T ATE207351T1 AT E207351 T1 ATE207351 T1 AT E207351T1 AT 94919708 T AT94919708 T AT 94919708T AT 94919708 T AT94919708 T AT 94919708T AT E207351 T1 ATE207351 T1 AT E207351T1
Authority
AT
Austria
Prior art keywords
modafinil
respiracy
pct
breathing discomfort
treat sleeping
Prior art date
Application number
AT94919708T
Other languages
English (en)
Inventor
Philippe Laurent
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9448411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE207351(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of ATE207351T1 publication Critical patent/ATE207351T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT94919708T 1993-06-22 1994-06-14 Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden ATE207351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307555A FR2706767B1 (de) 1993-06-22 1993-06-22
PCT/FR1994/000711 WO1995000132A1 (fr) 1993-06-22 1994-06-14 Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale

Publications (1)

Publication Number Publication Date
ATE207351T1 true ATE207351T1 (de) 2001-11-15

Family

ID=9448411

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919708T ATE207351T1 (de) 1993-06-22 1994-06-14 Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden

Country Status (14)

Country Link
US (1) US5612379A (de)
EP (1) EP0705099B1 (de)
JP (1) JP3703831B2 (de)
KR (1) KR100315389B1 (de)
AT (1) ATE207351T1 (de)
AU (1) AU684087B2 (de)
CA (1) CA2165824C (de)
DE (1) DE69428791T2 (de)
DK (1) DK0705099T3 (de)
ES (1) ES2165878T3 (de)
FR (1) FR2706767B1 (de)
HU (1) HU216731B (de)
PT (1) PT705099E (de)
WO (1) WO1995000132A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
DK1066036T3 (da) 1998-02-27 2006-08-21 Univ Illinois Midler med serotoninrelateret aktivitet til behandling af sövnapnö
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
AU1167702A (en) * 2000-10-11 2002-04-22 Cephalon Inc Compositions comprising modafinil compounds
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
ES2281527T3 (es) * 2001-05-25 2007-10-01 Cephalon, Inc. Formulaciones farmaceuticas solidas que comprenden modafinilo.
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia
DK1610796T3 (da) * 2003-03-17 2014-07-21 Neurohealing Pharmaceuticals Inc Højpotent dopaminerg behandling af neurologisk svækkelse, som er forbundet med hjerneskade
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
EP1586560A1 (de) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituierte Arylmethansulfinyl-Derivate
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
CA2590802A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
US20090123545A1 (en) * 2005-07-21 2009-05-14 Ron Eyal S Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof
JP2009543803A (ja) * 2006-07-12 2009-12-10 エラン・ファルマ・インターナショナル・リミテッド モダフィニルのナノ粒子製剤
EP2056811B8 (de) * 2006-08-14 2018-03-21 Neurohealing Pharmaceuticals, Inc. Behandlung auf modafinilbasis gegen vorzeitige ejakulation
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20100010092A1 (en) * 2006-12-19 2010-01-14 Arless Ltd. Use of modafinil to treat restless leg syndrome
EP2521546A4 (de) * 2010-01-07 2013-06-26 Vivus Inc Behandlung des obstruktiven schlafapnoesyndroms mit einer kombination aus kohlenstoffanhydrasehemmer und einem zusätzlichen wirkstoff
EP3854409A1 (de) 2013-08-30 2021-07-28 Green Cross Wellbeing Corporation Zusammensetzung mit verarbeitetem ginseng-pulver oder verarbeitetem ginseng-extrakt mit erhöhtem gehalt des ginsenosidbestandteils zur vorbeugung und behandlung von krebsbedingter fatigue
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
CA2165824C (fr) 2005-08-02
PT705099E (pt) 2002-03-28
DE69428791D1 (de) 2001-11-29
FR2706767A1 (de) 1994-12-30
DE69428791T2 (de) 2002-07-04
JP3703831B2 (ja) 2005-10-05
JPH09500374A (ja) 1997-01-14
AU684087B2 (en) 1997-12-04
ES2165878T3 (es) 2002-04-01
AU7076094A (en) 1995-01-17
EP0705099B1 (de) 2001-10-24
DK0705099T3 (da) 2002-02-11
CA2165824A1 (fr) 1995-01-05
HU216731B (hu) 1999-08-30
KR960703009A (ko) 1996-06-19
US5612379A (en) 1997-03-18
KR100315389B1 (ko) 2002-02-19
EP0705099A1 (de) 1996-04-10
HUT74674A (en) 1997-01-28
FR2706767B1 (de) 1995-09-08
HU9503702D0 (en) 1996-02-28
WO1995000132A1 (fr) 1995-01-05

Similar Documents

Publication Publication Date Title
ATE207351T1 (de) Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
DE60207383D1 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
DE69400435D1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69527052D1 (de) Verwendung von Wasser mit verringertem Deuterium-Gehalt zur Herstellung von hygienischen und kosmetischen Präparaten
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
ATE210447T1 (de) Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
DE602005026276D1 (de) Myricitrin verbindungen zur behandlung von schlafstörungen
ATE241981T1 (de) Verwendung von 4-aminopyridin zur behandlung von schmerz und spastik folgende einer verletzung des rückenmarks
ATE159937T1 (de) 1,4-disubstituierte piperazine zur behandlung von asthma und entzündungen der atemwege
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE190839T1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
ATE408602T1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
DE69400702D1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE239458T1 (de) Verwendung von selegilin zur behandlung von epileptischen erkrankungen
DE50105253D1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
ATE186640T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen
DE59409813D1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification